申请人:THE WELLCOME FOUNDATION LIMITED
公开号:EP0461815A1
公开(公告)日:1991-12-18
This invention relates to 1-(β-D-Arabinofuranosyl)5-prop-1-ynyluracil and pharmaceutically acceptable derivatives thereof for use in the treatment of hepatitis viral infections, particularly hepatitis B viral infections.
本发明涉及1-(β-D-阿拉伯
呋喃糖基)5-
丙炔基尿
嘧啶及其药学上可接受的衍
生物,用于治疗病毒性肝炎,特别是乙型病毒性肝炎。